Morgan Stanley Maintains Overweight on Axonics Modulation Tech, Raises Price Target to $42

Morgan Stanley maintains Axonics Modulation Tech (NASDAQ:AXNX) with a Overweight and raises the price target from $40 to $42.

Benzinga · 11/15/2019 13:29

Morgan Stanley maintains Axonics Modulation Tech (NASDAQ:AXNX) with a Overweight and raises the price target from $40 to $42.